IEQ Capital’s Abiomed Inc ABMD Stock Holding History

IEQ Capital’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,232	Closed	-$303K	–	912
2022 Q3	$303K	Buy	+1,232	New	+$333K	0.01%	666
2022 Q2	–	Sell	-902	Closed	-$299K	–	873
2022 Q1	$299K	Buy	902 +316	+54%	+$97.3K	0.01%	640
2021 Q4	$210K	Buy	+586	New	+$198K	﹤0.01%	684

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

IEQ Capital's ABMD Position: Q4 2022 in Review

IEQ Capital sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,232 shares — an estimated $303K sold.

IEQ Capital first reported a position in ABMD in Q4 2021 and held it in 3 quarters. The position peaked at $303K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

IEQ Capital reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
IEQ Capital sold 1,232 Abiomed Inc shares in Q4 2022, an estimated $303K.
IEQ Capital first reported a position in Abiomed Inc in Q4 2021 and held it in 3 quarters.
IEQ Capital's Abiomed Inc position peaked at $303K in Q3 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on IEQ Capital's 13F filing for Q4 2022, filed 6 Feb 2023.